Collectively, the aforementioned studies indicate that upregulation of PI3K/Akt signaling through dialogue with various miRNA can exert positive effects on β‐cell function and survival, and, as such, these miRNA represent viable therapeutics/targets for the treatment of T1D. The gene discussed is PIK3CD; the disease is type 1 diabetes mellitus.